Gary Jay Brenner, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurilemmoma | 13 | 2023 | 526 | 4.860 |
Why?
|
| Salmonella typhimurium | 3 | 2023 | 347 | 1.580 |
Why?
|
| Dependovirus | 4 | 2022 | 718 | 1.390 |
Why?
|
| CARD Signaling Adaptor Proteins | 2 | 2022 | 159 | 1.310 |
Why?
|
| Genetic Vectors | 4 | 2022 | 3396 | 0.940 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2021 | 59 | 0.750 |
Why?
|
| Tegmentum Mesencephali | 1 | 2019 | 59 | 0.670 |
Why?
|
| Gene Transfer Techniques | 3 | 2022 | 1206 | 0.670 |
Why?
|
| Myelin P0 Protein | 1 | 2019 | 15 | 0.670 |
Why?
|
| Neurofibromatosis 2 | 2 | 2021 | 385 | 0.660 |
Why?
|
| Myelin Proteins | 1 | 2019 | 209 | 0.620 |
Why?
|
| Ventral Tegmental Area | 1 | 2019 | 136 | 0.610 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2019 | 93 | 0.600 |
Why?
|
| Posterior Horn Cells | 6 | 2009 | 91 | 0.530 |
Why?
|
| Caspase 1 | 2 | 2013 | 225 | 0.470 |
Why?
|
| Sciatic Nerve | 4 | 2013 | 617 | 0.450 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2022 | 3605 | 0.450 |
Why?
|
| Injections, Epidural | 1 | 2015 | 201 | 0.430 |
Why?
|
| Pain | 9 | 2021 | 5073 | 0.430 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2021 | 0.430 |
Why?
|
| Schwann Cells | 2 | 2013 | 197 | 0.410 |
Why?
|
| Transduction, Genetic | 4 | 2022 | 903 | 0.380 |
Why?
|
| Luciferases, Firefly | 1 | 2010 | 37 | 0.370 |
Why?
|
| Injections, Intralesional | 3 | 2022 | 280 | 0.360 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2019 | 916 | 0.360 |
Why?
|
| Transgenes | 3 | 2022 | 1010 | 0.360 |
Why?
|
| Analgesics, Opioid | 2 | 2019 | 3808 | 0.340 |
Why?
|
| Spinal Cord | 6 | 2009 | 1819 | 0.320 |
Why?
|
| Mice | 30 | 2023 | 81539 | 0.320 |
Why?
|
| Neural Pathways | 1 | 2019 | 3060 | 0.310 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 2872 | 0.310 |
Why?
|
| Nociceptors | 6 | 2010 | 461 | 0.310 |
Why?
|
| Luminescent Proteins | 1 | 2010 | 837 | 0.300 |
Why?
|
| Anesthesiology | 2 | 2021 | 1120 | 0.290 |
Why?
|
| Mice, Nude | 6 | 2021 | 3614 | 0.280 |
Why?
|
| Apoptosis | 2 | 2022 | 9490 | 0.280 |
Why?
|
| Hyperalgesia | 7 | 2010 | 532 | 0.280 |
Why?
|
| Animals | 41 | 2023 | 168475 | 0.280 |
Why?
|
| Immunotherapy | 1 | 2022 | 4652 | 0.270 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 1881 | 0.260 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 1667 | 0.230 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 5821 | 0.230 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2022 | 2467 | 0.230 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2008 | 895 | 0.220 |
Why?
|
| Low Back Pain | 1 | 2012 | 984 | 0.220 |
Why?
|
| Protein Kinase C | 2 | 2004 | 1202 | 0.210 |
Why?
|
| Bradykinin | 3 | 2008 | 208 | 0.200 |
Why?
|
| Disease Models, Animal | 5 | 2022 | 18255 | 0.190 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 16990 | 0.190 |
Why?
|
| Heat-Shock Proteins | 2 | 2011 | 795 | 0.190 |
Why?
|
| Molecular Chaperones | 2 | 2011 | 754 | 0.180 |
Why?
|
| Sciatic Neuropathy | 1 | 2021 | 76 | 0.180 |
Why?
|
| Serine | 1 | 2004 | 831 | 0.180 |
Why?
|
| Curriculum | 2 | 2018 | 3743 | 0.180 |
Why?
|
| Herpesvirus 1, Human | 2 | 1997 | 753 | 0.170 |
Why?
|
| Vestibulocochlear Nerve | 1 | 2019 | 115 | 0.160 |
Why?
|
| Receptors, Opioid | 1 | 2019 | 145 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 3 | 2019 | 5790 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 5493 | 0.160 |
Why?
|
| Neoplasms, Experimental | 2 | 2022 | 1229 | 0.160 |
Why?
|
| Gene Expression | 3 | 2022 | 7581 | 0.150 |
Why?
|
| Neural Cell Adhesion Molecules | 2 | 2010 | 122 | 0.140 |
Why?
|
| Nucleus Accumbens | 1 | 2019 | 366 | 0.140 |
Why?
|
| Immunohistochemistry | 4 | 2022 | 11076 | 0.140 |
Why?
|
| Practice Management, Medical | 1 | 2018 | 191 | 0.130 |
Why?
|
| Anesthetics, Inhalation | 1 | 2021 | 574 | 0.130 |
Why?
|
| Nerve Regeneration | 2 | 2011 | 795 | 0.130 |
Why?
|
| Brain Stem | 1 | 2021 | 858 | 0.130 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2011 | 842 | 0.130 |
Why?
|
| Peripheral Nervous System | 2 | 2007 | 151 | 0.130 |
Why?
|
| Neuroma, Acoustic | 1 | 2019 | 459 | 0.120 |
Why?
|
| Morphine | 1 | 2019 | 657 | 0.120 |
Why?
|
| Consciousness | 1 | 2021 | 601 | 0.120 |
Why?
|
| Hearing | 1 | 2019 | 501 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 6 | 1997 | 6214 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 6131 | 0.120 |
Why?
|
| Inflammasomes | 1 | 2019 | 526 | 0.110 |
Why?
|
| Spinal Nerves | 1 | 2014 | 91 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 1252 | 0.110 |
Why?
|
| Herpes Simplex | 2 | 2009 | 478 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 4 | 2011 | 4415 | 0.110 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2019 | 1141 | 0.110 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2019 | 781 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2021 | 1878 | 0.110 |
Why?
|
| Stellate Ganglion | 1 | 2012 | 50 | 0.110 |
Why?
|
| Fellowships and Scholarships | 2 | 2021 | 1117 | 0.110 |
Why?
|
| Post-Traumatic Headache | 1 | 2014 | 65 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2019 | 1892 | 0.100 |
Why?
|
| Sympathetic Nervous System | 2 | 1994 | 518 | 0.100 |
Why?
|
| Cytosine Deaminase | 1 | 2012 | 66 | 0.100 |
Why?
|
| Motor Activity | 2 | 2021 | 2715 | 0.100 |
Why?
|
| Trigeminal Nerve | 1 | 2014 | 248 | 0.100 |
Why?
|
| Pain Clinics | 1 | 2012 | 50 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 9542 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 8 | 2013 | 22174 | 0.100 |
Why?
|
| Humans | 24 | 2023 | 761596 | 0.100 |
Why?
|
| Nerve Fibers, Unmyelinated | 3 | 2008 | 98 | 0.090 |
Why?
|
| Pandemics | 2 | 2021 | 8656 | 0.090 |
Why?
|
| Thermosensing | 1 | 2010 | 55 | 0.090 |
Why?
|
| Patient Simulation | 1 | 2012 | 298 | 0.090 |
Why?
|
| Resource Allocation | 1 | 2012 | 350 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2009 | 8181 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 2 | 2013 | 2065 | 0.090 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2010 | 130 | 0.080 |
Why?
|
| Neurites | 1 | 2011 | 391 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 1997 | 1403 | 0.080 |
Why?
|
| Signal Transduction | 7 | 2019 | 23447 | 0.080 |
Why?
|
| Nerve Block | 2 | 2014 | 706 | 0.080 |
Why?
|
| Pneumothorax | 1 | 2012 | 386 | 0.080 |
Why?
|
| Cell Survival | 1 | 2019 | 5791 | 0.080 |
Why?
|
| Autonomic Nervous System | 1 | 2014 | 703 | 0.080 |
Why?
|
| Resuscitation | 1 | 2012 | 673 | 0.080 |
Why?
|
| N-Methylaspartate | 2 | 2005 | 231 | 0.070 |
Why?
|
| Anaphylatoxins | 1 | 2007 | 21 | 0.070 |
Why?
|
| Killer Cells, Natural | 3 | 1994 | 2201 | 0.070 |
Why?
|
| Plasmids | 1 | 2013 | 2269 | 0.070 |
Why?
|
| Cervical Vertebrae | 1 | 2014 | 980 | 0.070 |
Why?
|
| Complement C5a | 1 | 2007 | 100 | 0.070 |
Why?
|
| Physical Stimulation | 2 | 2008 | 517 | 0.070 |
Why?
|
| Ganglia, Spinal | 4 | 2011 | 526 | 0.070 |
Why?
|
| Cold Temperature | 1 | 2010 | 785 | 0.070 |
Why?
|
| Axons | 2 | 2011 | 1674 | 0.070 |
Why?
|
| Pain Measurement | 6 | 2009 | 3551 | 0.070 |
Why?
|
| Rats | 10 | 2010 | 23741 | 0.070 |
Why?
|
| Genetic Engineering | 1 | 2012 | 933 | 0.070 |
Why?
|
| Medication Errors | 1 | 2012 | 783 | 0.070 |
Why?
|
| Receptors, AMPA | 1 | 2008 | 336 | 0.070 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2007 | 137 | 0.070 |
Why?
|
| Immunity | 1 | 1992 | 996 | 0.060 |
Why?
|
| Education, Medical | 1 | 2018 | 1725 | 0.060 |
Why?
|
| Simplexvirus | 1 | 2009 | 803 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2002 | 1246 | 0.060 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2005 | 70 | 0.060 |
Why?
|
| Analgesics | 1 | 2012 | 1070 | 0.060 |
Why?
|
| Anaphylaxis | 1 | 2012 | 757 | 0.060 |
Why?
|
| Sleep | 1 | 2021 | 4768 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2019 | 4399 | 0.060 |
Why?
|
| Male | 15 | 2021 | 360846 | 0.060 |
Why?
|
| Cannabinoids | 1 | 2007 | 172 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2022 | 64685 | 0.060 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 1882 | 0.060 |
Why?
|
| Substance P | 2 | 2004 | 335 | 0.060 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2004 | 127 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 7406 | 0.060 |
Why?
|
| Dizocilpine Maleate | 1 | 2004 | 172 | 0.060 |
Why?
|
| Sensory Receptor Cells | 1 | 2008 | 513 | 0.060 |
Why?
|
| Oncolytic Virotherapy | 1 | 2009 | 516 | 0.060 |
Why?
|
| Receptors, Glutamate | 1 | 2004 | 228 | 0.060 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4281 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10451 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 1994 | 3156 | 0.050 |
Why?
|
| Neuralgia | 1 | 2009 | 615 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 999 | 0.050 |
Why?
|
| Spleen | 4 | 1994 | 2295 | 0.050 |
Why?
|
| Cytokines | 2 | 1998 | 7396 | 0.050 |
Why?
|
| Analgesia | 1 | 2007 | 461 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 484 | 0.050 |
Why?
|
| Phosphorylation | 4 | 2011 | 8321 | 0.050 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2004 | 448 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2004 | 535 | 0.050 |
Why?
|
| Enkephalins | 1 | 2002 | 139 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2004 | 586 | 0.050 |
Why?
|
| Neurons | 2 | 2019 | 9463 | 0.050 |
Why?
|
| Action Potentials | 1 | 2008 | 1834 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2012 | 1923 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2008 | 1608 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2012 | 12794 | 0.050 |
Why?
|
| Carcinoma | 1 | 1992 | 2330 | 0.040 |
Why?
|
| Immune System | 2 | 1998 | 796 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 2009 | 1171 | 0.040 |
Why?
|
| Cell Count | 1 | 2004 | 1835 | 0.040 |
Why?
|
| Mice, Knockout | 6 | 2011 | 14417 | 0.040 |
Why?
|
| Temperature | 2 | 2004 | 2226 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2021 | 279 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2012 | 8633 | 0.040 |
Why?
|
| Synaptic Transmission | 1 | 2005 | 1173 | 0.040 |
Why?
|
| Prognosis | 1 | 2019 | 29629 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2011 | 4937 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 3251 | 0.040 |
Why?
|
| Microglia | 1 | 2007 | 1362 | 0.040 |
Why?
|
| Female | 11 | 2021 | 392705 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1971 | 0.040 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 11904 | 0.040 |
Why?
|
| Enzyme Activation | 4 | 2008 | 3597 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2010 | 3677 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2004 | 1440 | 0.040 |
Why?
|
| Accreditation | 1 | 2021 | 473 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2002 | 1132 | 0.040 |
Why?
|
| Cell Movement | 1 | 2009 | 5205 | 0.040 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 1998 | 115 | 0.040 |
Why?
|
| Electroshock | 1 | 1997 | 121 | 0.040 |
Why?
|
| Endocrine System | 1 | 1998 | 114 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2012 | 4793 | 0.030 |
Why?
|
| T-Lymphocytes | 3 | 2009 | 10194 | 0.030 |
Why?
|
| Brain Waves | 1 | 2021 | 409 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2004 | 5035 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 1992 | 13381 | 0.030 |
Why?
|
| Electrophysiology | 2 | 2010 | 1262 | 0.030 |
Why?
|
| Pain Threshold | 1 | 1999 | 604 | 0.030 |
Why?
|
| Oxidopamine | 2 | 1994 | 172 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3530 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2010 | 3816 | 0.030 |
Why?
|
| Lymphocyte Activation | 3 | 1994 | 5485 | 0.030 |
Why?
|
| Time Factors | 4 | 2011 | 39969 | 0.030 |
Why?
|
| Cells, Cultured | 4 | 2011 | 18966 | 0.030 |
Why?
|
| Stress, Psychological | 3 | 2021 | 4481 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 1994 | 309 | 0.030 |
Why?
|
| Pentosyltransferases | 1 | 2012 | 62 | 0.030 |
Why?
|
| Leukocyte Count | 2 | 1994 | 1596 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2012 | 5882 | 0.030 |
Why?
|
| Nerve Endings | 1 | 1992 | 105 | 0.030 |
Why?
|
| Motor Endplate | 1 | 2011 | 20 | 0.020 |
Why?
|
| Nerve Crush | 1 | 2011 | 77 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2011 | 66 | 0.020 |
Why?
|
| Capsaicin | 2 | 2004 | 231 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1992 | 242 | 0.020 |
Why?
|
| Denervation | 1 | 1992 | 265 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1994 | 1351 | 0.020 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2011 | 263 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 470 | 0.020 |
Why?
|
| p21-Activated Kinases | 1 | 2010 | 128 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 384 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 1992 | 2016 | 0.020 |
Why?
|
| Norepinephrine | 1 | 1992 | 897 | 0.020 |
Why?
|
| Luminescence | 1 | 2009 | 108 | 0.020 |
Why?
|
| Proteins | 1 | 2004 | 6032 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 2373 | 0.020 |
Why?
|
| Hindlimb | 2 | 2002 | 513 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 1994 | 1560 | 0.020 |
Why?
|
| Mice, Inbred C3H | 2 | 2005 | 915 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2002 | 641 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2008 | 262 | 0.020 |
Why?
|
| Urothelium | 1 | 2010 | 269 | 0.020 |
Why?
|
| Sodium Channel Blockers | 1 | 2008 | 173 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2010 | 4125 | 0.020 |
Why?
|
| Tetrodotoxin | 1 | 2008 | 246 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 1994 | 1889 | 0.020 |
Why?
|
| Biophysics | 1 | 2008 | 380 | 0.020 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2007 | 87 | 0.020 |
Why?
|
| Fluorescence | 1 | 2009 | 756 | 0.020 |
Why?
|
| Receptors, Complement | 1 | 2007 | 253 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1989 | 587 | 0.020 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2006 | 15 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2008 | 927 | 0.020 |
Why?
|
| Anxiety | 1 | 2021 | 4573 | 0.020 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2005 | 24 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 1994 | 3162 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 687 | 0.020 |
Why?
|
| Spermatocytes | 1 | 2005 | 40 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 3713 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 2007 | 498 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 2004 | 306 | 0.010 |
Why?
|
| Cell Division | 1 | 1992 | 4465 | 0.010 |
Why?
|
| Membrane Microdomains | 1 | 2005 | 206 | 0.010 |
Why?
|
| Telemedicine | 1 | 2021 | 3052 | 0.010 |
Why?
|
| Epididymis | 1 | 2005 | 228 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 6075 | 0.010 |
Why?
|
| DNA Primers | 1 | 2007 | 2820 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5774 | 0.010 |
Why?
|
| Imidazoles | 1 | 2008 | 1180 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 2386 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2004 | 795 | 0.010 |
Why?
|
| Butadienes | 1 | 2002 | 107 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 502 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 2002 | 149 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2004 | 615 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1990 | 2612 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2010 | 2425 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 22176 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2007 | 710 | 0.010 |
Why?
|
| Uterus | 1 | 2005 | 649 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2005 | 1757 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1900 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2011 | 2979 | 0.010 |
Why?
|
| Injections, Spinal | 1 | 2002 | 318 | 0.010 |
Why?
|
| Radiography | 1 | 1992 | 6965 | 0.010 |
Why?
|
| Ovary | 1 | 2005 | 959 | 0.010 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2004 | 602 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1994 | 4758 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2007 | 1336 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1989 | 2302 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2005 | 1176 | 0.010 |
Why?
|
| Physicians | 1 | 2018 | 4591 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2004 | 1736 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2005 | 3094 | 0.010 |
Why?
|
| Cell Line | 1 | 2012 | 15601 | 0.010 |
Why?
|
| Formaldehyde | 1 | 1999 | 358 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1999 | 332 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4576 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 3701 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1990 | 4544 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 220921 | 0.010 |
Why?
|
| Pyridines | 1 | 2008 | 2875 | 0.010 |
Why?
|
| Nitriles | 1 | 2002 | 971 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 10766 | 0.010 |
Why?
|
| Neurosecretory Systems | 1 | 1998 | 223 | 0.010 |
Why?
|
| Alleles | 1 | 2007 | 6864 | 0.010 |
Why?
|
| Health | 1 | 1998 | 398 | 0.010 |
Why?
|
| Nervous System | 1 | 1998 | 545 | 0.010 |
Why?
|
| Neoplasm Metastasis | 2 | 1998 | 4915 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 1998 | 483 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 7048 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1998 | 659 | 0.010 |
Why?
|
| Sympathectomy, Chemical | 1 | 1994 | 25 | 0.010 |
Why?
|
| Liver | 1 | 1990 | 7528 | 0.010 |
Why?
|
| Eye | 1 | 1998 | 712 | 0.010 |
Why?
|
| Age Factors | 1 | 2009 | 18399 | 0.010 |
Why?
|
| Disease | 1 | 1998 | 672 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1998 | 974 | 0.010 |
Why?
|
| Lung | 1 | 1990 | 10002 | 0.010 |
Why?
|
| Lymphokines | 1 | 1994 | 927 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1994 | 852 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 7859 | 0.010 |
Why?
|
| Animals, Laboratory | 1 | 1990 | 46 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1992 | 1395 | 0.000 |
Why?
|
| Lipopolysaccharides | 1 | 1994 | 2206 | 0.000 |
Why?
|
| Autoimmune Diseases | 1 | 1998 | 2244 | 0.000 |
Why?
|
| Immunization | 1 | 1990 | 1227 | 0.000 |
Why?
|
| Random Allocation | 1 | 1990 | 2395 | 0.000 |
Why?
|
| Glucocorticoids | 1 | 1992 | 2161 | 0.000 |
Why?
|
| Inflammation | 1 | 2002 | 10774 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1990 | 6228 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1990 | 5870 | 0.000 |
Why?
|
| Adult | 1 | 2014 | 221210 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1994 | 11530 | 0.000 |
Why?
|